Sanofi
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$336.0M
Q ending 2026-03-31
Prior quarter
$310.4M
Q ending 2025-12-31
Change
+8.2% QoQ · +102.5% YoY
Positions
9
reported holdings
Largest positions
All 9 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Meiragtx Holdings Plc | Shares | $105.6M | 12.2M | |
| Inhibrx Biosciences, Inc. | INBX | Shares | $77.8M | 1.2M |
| Novavax | NVAX | Shares | $56.0M | 6.9M |
| Anaptysbio | ANAB | Shares | $30.4M | 822K |
| Agomab Therapeutics Nv | AGMB | Shares | $29.2M | 2.8M |
| Maplight Therapeutics Inc. | MPLT | Shares | $18.5M | 912K |
| Immuneering Corp | IMRX | Shares | $14.3M | 2.7M |
| Eledon | ELDN | Shares | $2.5M | 815K |
| Q32 Bio Inc. | QTTB | Shares | $1.6M | 244K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.